Olabir Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. This medication can be given alone or in combination with other anticancer drugs.

It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting therapy, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.

It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Olabir Tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins and supplements.

VERY SECURE PAYMENT METHODS
SHIPPING WILL BE CALCULATED ON CHECKOUT
PLEASE NOTE THAT PRICES MAY INCREASE DUE TO EXCHANGE RATE, ENSURE UPDATED PRICE BEFORE MAKING PAYMENT